CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −534 | $30.09 | $16K | 81,948 |
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −534 | $30.09 | $16K | 70,845 |
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −171 | $30.09 | $5K | 8,356 |
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $30.09 | $5K | 8,356 |
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $30.09 | $5K | 8,356 |
| 2024-08-23 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −169 | $30.09 | $5K | 8,356 |
| 2024-08-12 | BRADBURY DANIEL Director | Sale 10b5-1 | −5,021 | $26.65 | $134K | 30,102 |
| 2024-08-12 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,431 | $26.65 | $38K | 8,550 |
| 2024-08-12 | BRADBURY DANIEL Director | Sale 10b5-1 | −1,431 | $26.65 | $38K | 8,550 |
| 2024-08-09 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Grant or award | +66,991 | 124,884 | ||
| 2024-08-09 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Shares withheld for taxes | −21,828 | $26.83 | $586K | 103,056 |
| 2024-08-09 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Grant or award · Performance-Based Stock Unit | +66,991 | 66,991 | ||
| 2024-08-09 | Juvenal Tobin W Chief Commercial Officer | Grant or award | +10,641 | 58,770 | ||
| 2024-08-09 | Juvenal Tobin W Chief Commercial Officer | Shares withheld for taxes | −2,592 | $26.83 | $70K | 56,178 |
| 2024-08-09 | Juvenal Tobin W Chief Commercial Officer | Grant or award · Performance-Based Stock Unit | +10,641 | 10,641 | ||
| 2024-08-09 | Oelschlager Kristen M Chief Operating Officer | Grant or award | +10,641 | 143,477 | ||
| 2024-08-09 | Oelschlager Kristen M Chief Operating Officer | Shares withheld for taxes | −2,804 | $26.83 | $75K | 140,673 |
| 2024-08-09 | Oelschlager Kristen M Chief Operating Officer | Grant or award · Performance-Based Stock Unit | +10,640 | 10,640 | ||
| 2024-08-09 | Stokes Frank Chief Financial Officer | Grant or award | +9,745 | 40,568 | ||
| 2024-08-09 | Stokes Frank Chief Financial Officer | Shares withheld for taxes | −2,822 | $26.83 | $76K | 37,746 |
Page 38 of 45 · 897 trades